Explained herein are pharmaceutical packaging systems which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, such units together with a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen and comprise